AptarGroup ATR Pharma — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AptarGroup in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about AptarGroup's pharma — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AptarGroup's pharma — goodwill?
- AptarGroup (ATR) reported pharma — goodwill of $534.34M in Q1 2026.
- What does pharma — goodwill mean?
- Represents the premium paid over the fair value of net assets during acquisitions within the pharmaceutical segment. It reflects the value of intangible assets such as brand reputation, customer relationships, and proprietary technology acquired to bolster the segment's market position.